The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study
暂无分享，去创建一个
J. Sancho | U. Jaeger | G. Follows | J. Kuruvilla | J. Zijlstra | N. Kalakonda | S. Choquet | B. Hill | F. Cavallo | J. Vermaat | M. Schuster | F. Offner | K. Warzocha | C. Thieblemont | J. Shah | P. Caimi | R. Casasnovas | T. Vassilakopoulos | S. Bakhshi | R. Gurion | M. Maerevoet | N. Hamad | K. Chamoun | M. Egyed | P. Samal | K. Corona | M. Canales | M. Ku | F. Cruz | Jenny Xu